Hot Stock under Review: NRX Pharmaceuticals Inc (NASDAQ:NRXP 27.50%), Cemex S.A.B. De C.V. ADR (NYSE:CX -0.77%)
NRXP has seen its SMA50 which is now 53.61%. In looking the SMA 200 we see that the stock has seen a 68.83%. CX has seen its SMA50 which is …
Read More